Intravenous immune globulin for multiple sclerosis.
D054598:Blue Cross Blue Shield Insurance Plans; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000145:classification / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D016756:Immunoglobulins, Intravenous